Maternal and Perinatal Pregnancy Outcome in Women With Heterozygous Hemoglobinopathies
NCT ID: NCT03837119
Last Updated: 2024-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
540 participants
OBSERVATIONAL
2018-04-04
2021-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heterozygous Hemoglobinopathy
pregnancy outcome in women with heterozygous hemoglobinopathy
pregnancy outcome
descriptive statistics of variables
No Heterozygous Hemoglobinopathy
pregnancy outcome in women without heterozygous hemoglobinopathy
pregnancy outcome
descriptive statistics of variables
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pregnancy outcome
descriptive statistics of variables
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irene Hoesli, Prof. Dr. MD
Role: PRINCIPAL_INVESTIGATOR
Frauenklinik Universitätsspital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Frauenklinik University Hospital Basel
Basel, , Switzerland
Frauenklinik University Hospital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kasparek J, Burkhardt T, Hoesli I, Amstad Bencaiova G. Pregnancy outcomes in women with a hemoglobinopathy trait: a multicenter, retrospective study. Arch Gynecol Obstet. 2021 Nov;304(5):1197-1203. doi: 10.1007/s00404-021-06058-y. Epub 2021 Apr 11.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-00101; sp19Hoesli
Identifier Type: -
Identifier Source: org_study_id